Alaunos Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold TCRT, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
7
Funds holding
$54322
Total value held
Buying
6 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $48258 | 21353 | — | Held |
| 2 | Ubs Group Ag | $2242 | 992 | +992 | NEW BUY |
| 3 | Morgan Stanley | $1889 | 836 | +183 | +28.02% |
| 4 | Royal Bank Of Canada | $1000 | 375 | +190 | +102.70% |
| 5 | Wells Fargo & Company/Mn | $877 | 388 | +198 | +104.21% |
| 6 | Barclays Plc | $34 | 15 | +15 | NEW BUY |
| 7 | Amalgamated Financial Corp. | $22 | 34236 | +34236 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.